Literature DB >> 15831939

Expression of membrane type 1 matrix metalloproteinase in papillomavirus-positive cells: role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products.

Sigrun Smola-Hess1, Jenny Pahne1, Cornelia Mauch2, Paola Zigrino2, Hans Smola2, Herbert J Pfister1.   

Abstract

Matrix metalloproteinases (MMPs) degrade extracellular matrix. They are involved in cellular proliferation, migration, angiogenesis, invasion and metastasis. MT-1 MMP, a membrane-bound MMP, is expressed in carcinomas of the uterine cervix in vivo. This type of cancer is associated with human papillomavirus (HPV) infection. Here it was shown that keratinocytes transformed with HPV16 or HPV18 in vitro, and HPV-positive cervical carcinoma cell lines, constitutively expressed MT-1 MMP. Expression of the E7 protein from the mucosal and cutaneous high-risk types HPV16 and HPV8, but not from the cutaneous low-risk type HPV1, was sufficient to induce MT-1 MMP expression in primary human keratinocytes and HaCaT cells. As a consequence, MMP-2 was activated. MT-1 MMP expression might play a role in the HPV life cycle by promoting proliferation of host cells and might contribute to their invasive phenotype during malignant progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831939     DOI: 10.1099/vir.0.80551-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  The E2 protein of human papillomavirus type 8 increases the expression of matrix metalloproteinase-9 in human keratinocytes and organotypic skin cultures.

Authors:  Baki Akgül; Ramón García-Escudero; Christine Ekechi; Gertrud Steger; Harshad Navsaria; Herbert Pfister; Alan Storey
Journal:  Med Microbiol Immunol       Date:  2011-01-28       Impact factor: 3.402

Review 2.  Beta genus papillomaviruses and skin cancer.

Authors:  Peter M Howley; Herbert J Pfister
Journal:  Virology       Date:  2015-02-24       Impact factor: 3.616

Review 3.  The human papillomavirus E7 oncoprotein as a regulator of transcription.

Authors:  William K Songock; Seong-Man Kim; Jason M Bodily
Journal:  Virus Res       Date:  2016-11-08       Impact factor: 3.303

Review 4.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

5.  E6/E7 oncoproteins of high risk HPV-16 upregulate MT1-MMP, MMP-2 and MMP-9 and promote the migration of cervical cancer cells.

Authors:  Dingjun Zhu; Mei Ye; Wei Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

6.  Ras modifies proliferation and invasiveness of cells expressing human papillomavirus oncoproteins.

Authors:  Satoshi Yoshida; Naoko Kajitani; Ayano Satsuka; Hiroyasu Nakamura; Hiroyuki Sakai
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

Review 7.  The papillomavirus E7 proteins.

Authors:  Ann Roman; Karl Munger
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

8.  Human papillomavirus up-regulates MMP-2 and MMP-9 expression and activity by inducing interleukin-8 in lung adenocarcinomas.

Authors:  Ming-Yuh Shiau; Li-Ching Fan; Shun-Chun Yang; Chang-Hui Tsao; Huei Lee; Ya-Wen Cheng; Li-Chuan Lai; Yih-Hsin Chang
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

9.  Human papillomavirus type 8 interferes with a novel C/EBPβ-mediated mechanism of keratinocyte CCL20 chemokine expression and Langerhans cell migration.

Authors:  Tanya Sperling; Monika Ołdak; Barbara Walch-Rückheim; Claudia Wickenhauser; John Doorbar; Herbert Pfister; Magdalena Malejczyk; Sławomir Majewski; Andrew C Keates; Sigrun Smola
Journal:  PLoS Pathog       Date:  2012-07-26       Impact factor: 6.823

10.  HPV16 oncoproteins promote cervical cancer invasiveness by upregulating specific matrix metalloproteinases.

Authors:  Jittranan Kaewprag; Wareerat Umnajvijit; Jarunya Ngamkham; Mathurose Ponglikitmongkol
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.